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Abstract
Background Although advances in cardiopulmonary resuscitation have improved survival from cardiac arrest
(CA), neurologic injury persists and impaired mitochondrial bioenergetics may be critical for targeted
neuroresuscitation. The authors sought to determine if excellent cardiopulmonary resuscitation and
postresuscitation care and good traditional survival rates result in persistently disordered cerebral
mitochondrial bioenergetics in a porcine pediatric model of asphyxia‐associated ventricular fibrillation CA.
Methods and Results After 7 minutes of asphyxia, followed by ventricular fibrillation, 5 female 1‐month‐old
swine (4 sham) received blood pressure–targeted care: titration of compression depth to systolic blood
pressure of 90 mm Hg and vasopressor administration to a coronary perfusion pressure >20 mm Hg. All
animals received protocol‐based vasopressor support after return of spontaneous circulation for 4 hours
before they were killed. The primary outcome was integrated mitochondrial electron transport system (ETS)
function. CA animals displayed significantly decreased maximal, coupled oxidative phosphorylating
respiration (OXPHOSCI+CII) in cortex (PPPPCI PCII PCIPCII PCI+CII), as well as a 30% reduction in
citrate synthase activity (P<0.04).
Conclusions Mitochondria in both the cortex and hippocampus displayed significant alterations in respiratory
function after CA despite excellent cardiopulmonary resuscitation and postresuscitation care in
asphyxia‐associated ventricular fibrillation CA. Analysis of integrated ETS function identifies mitochondrial
bioenergetic failure as a target for goal‐directed neuroresuscitation after CA. IACUC Protocol: IAC
13‐001023.
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Background-—Although advances in cardiopulmonary resuscitation have improved survival from cardiac arrest (CA), neurologic
injury persists and impaired mitochondrial bioenergetics may be critical for targeted neuroresuscitation. The authors sought to
determine if excellent cardiopulmonary resuscitation and postresuscitation care and good traditional survival rates result in
persistently disordered cerebral mitochondrial bioenergetics in a porcine pediatric model of asphyxia-associated ventricular
ﬁbrillation CA.
Methods and Results-—After 7 minutes of asphyxia, followed by ventricular ﬁbrillation, 5 female 1-month-old swine (4 sham)
received blood pressure–targeted care: titration of compression depth to systolic blood pressure of 90 mm Hg and vasopressor
administration to a coronary perfusion pressure >20 mm Hg. All animals received protocol-based vasopressor support after return
of spontaneous circulation for 4 hours before they were killed. The primary outcome was integrated mitochondrial electron
transport system (ETS) function. CA animals displayed signiﬁcantly decreased maximal, coupled oxidative phosphorylating
respiration (OXPHOSCI+CII) in cortex (P<0.02) and hippocampus (P<0.02), as well as decreased phosphorylation and coupling
efﬁciency (cortex, P<0.05; hippocampus, P<0.05). Complex I– and complex II–driven respiration were both signiﬁcantly decreased
after CA (cortex: OXPHOSCI P<0.01, ETSCII P<0.05; hippocampus: OXPHOSCI P<0.03, ETSCII P<0.01). In the hippocampus, there
was a signiﬁcant decrease in maximal uncoupled, nonphosphorylating respiration (ETSCI+CII), as well as a 30% reduction in citrate
synthase activity (P<0.04).
Conclusions-—Mitochondria in both the cortex and hippocampus displayed signiﬁcant alterations in respiratory function after CA
despite excellent cardiopulmonary resuscitation and postresuscitation care in asphyxia-associated ventricular ﬁbrillation CA.
Analysis of integrated ETS function identiﬁes mitochondrial bioenergetic failure as a target for goal-directed neuroresuscitation
after CA. IACUC Protocol: IAC 13-001023. ( J Am Heart Assoc. 2015;4:e002232 doi: 10.1161/JAHA.115.002232)
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P ediatric cardiac arrest (CA) is an important public healthproblem, with thousands of children sustaining one of
these potentially devastating events each year in the United
States.1 Although survival rates are improving, many survivors
have neurologic sequelae, resulting in a major burden for
patients, families, and society.2 The brain is particularly
susceptible to ischemic injury because of its high metabolic
energy demand and limited intrinsic energy supply.
Alterations in mitochondrial bioenergetics may play a pivotal
role in secondary neurologic injury cascades, sometimes also
referred to as ischemia–reperfusion injury, initiated by CA in
mature animals.3,4 Several laboratories report critical alter-
ations in adult brain mitochondrial bioenergetics after ischemia
and reperfusion, including diminished mitochondrial mass,
population number, decreased function of the electron trans-
port system, reduced antioxidant enzyme activity and content,
and damaged and oxidized lipid membrane parameters.3,5,6
Because the immature brain has unique energetics compared
with older animals, the effects of CA on cerebral mitochondrial
bioenergetics may be different in immature animals.7,8
To address the paucity of data regarding mitochondrial
alterations in the immature brain after CA and cardiopulmonary
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resuscitation (CPR), we performed a detailed evaluation of
mitochondrial bioenergetics in a large animal model of hypoxic
ventricular ﬁbrillation (VF) pediatric CA that results in good
survival rates.9,10 We implemented high-resolution respirome-
try to ascertain integrated globalmitochondrial function, as well
as relative contributions of individual electron transport com-
plexes by using speciﬁc substrate and inhibitor combinations,
together with measures of mitochondrial functional content.
We hypothesized that despite good survival parameters after
CA and excellent CPR with explicit, protocolized postresusci-
tative care, pediatric animals would have global persistent
alterations in cerebral mitochondrial bioenergetics, mitochon-
drial content, and speciﬁc patterns of individual electron
complex dysfunction.
Materials and Methods
All procedures were approved by The Children’s Hospital of
Philadelphia’s Institutional Animal Care and Use Committee.
Four-week-old female piglets (N=9, 8 to 10 kg), which have
neurodevelopment comparable to that of a human toddler,
were used for the study.11,12 Piglets were designated into 2
cohorts: (1) the CA group (n=5) killed 4 hours after CPR and
return of spontaneous circulation (ROSC), 5 hours after the
initiation of anesthesia; and (2) anesthetized sham animals
(n=5) with no CA and no CPR killed 5 hours after the
induction of anesthesia.
Animal Preparation
A porcine model was chosen because of the similarities
between swine and humans in regard to anterior–posterior
chest depth and compression characteristics (eg, chest
stiffness), because the neuroanatomy and neurodevelopment
are similar to those of a human toddler, and because of
improved survival with the use of blood pressure–targeted
CPR in an asphyxia-associated VF CA.10,11,13,14 To keep the
population as homogeneous as possible, we did not investi-
gate male animal responses based on prior work.15 All piglets
were anesthetized and mechanically ventilated on a mixture of
room air and titrated isoﬂurane (1.0% to 2.5%) with a tidal
volume of 10 to 12 mL/kg, positive end-expiratory pressure
of 6 cm H2O, and titration of rate to maintain end-tidal carbon
dioxide at 38 to 42 mm Hg (NICO, Novametrix Medical
Systems Inc). High-ﬁdelity, solid-state, micromanometer-
tipped catheters (MPC-500; Millar Instruments) were used
to measure continuous aortic and right atrial pressures,
respectively. A bipolar pacing catheter (Edwards Lifesciences)
was used to induce VF. All catheter placements were
conﬁrmed with the use of ﬂuoroscopy. Unfractionated heparin
200 U/kg was provided to prevent catheter clotting. All
animals received a 20 mL/kg 0.9% normal saline bolus
intravenously before we obtained baseline measurements to
replace overnight fasting deﬁcits. Animals were prepared in a
similar fashion as detailed in our previous publications.16,17
Experimental Protocol: CA Animals
Our group has established that hemodynamically targeted
CPR titrated to arterial blood pressure improves short-term
survival compared with standard CPR targeted to a ﬁxed
depth of compressions and a ﬁxed frequency of vasoactive
medications after hypoxic and normoxic VF CA.15,16 This goal-
directed approach optimizes coronary perfusion pressure
(CPP) and cerebral perfusion pressure and presumably
coronary and cerebral blood ﬂow during CPR. In addition,
our well-established protocol used in this experiment was
designed to mimic resuscitation occurring in an intensive care
unit after a respiratory deterioration with an initial docu-
mented rhythm of VF (Figure 1).10,16 We selected 7 minutes
of asphyxia, plus 10 minutes of CPR, for a total 17 minutes of
CA because this insult is clinically relevant and because our
prior experience suggested that the majority of these animals
would be successfully resuscitated so that we could examine
mitochondria 4 hours after the injury.15,16 This model main-
tains important clinical relevance because most in-hospital
pediatric arrests occur in invasively monitored intensive care
unit patients.17,18 Ten minutes of CPR was performed before
the ﬁrst deﬁbrillation attempt to mimic the median duration of
clinical CPR in the in-hospital CPR setting.10,18,19
Asphyxial and Resuscitation Periods: CA Animals
We selected 7 minutes of asphyxia, plus 10 minutes of CPR
for a total 17 minutes of CA because this insult is both
clinically relevant and our prior experience suggested that the
majority of these animals would be successfully resuscitated
so that we could examine mitochondria 4 hours after the
injury.17 This model maintains important clinical relevance
because most in-hospital pediatric arrests occur in invasively
monitored intensive care unit patients.18,19 Endotracheal tube
clamping was conﬁrmed by absence of exhaled CO2 (Time 0).
After 7 minutes of tracheal tube clamping with severe arterial
hypoxemia, VF was induced and maintained by electrical
pacing to ensure that the animal would not have ROSC from
CPR alone before 10 minutes of CPR.20,21 Once VF was
conﬁrmed, the tracheal tube was unclamped and CPR was
started. Compressions were provided with a target rate of
100 min1 and ventilations at 6 min1 with 100% oxygen. To
ensure rigorous adherence to CPR rate goals, a metronome
was used. Brief, planned interruptions in CPR of 4 seconds
every 2 minutes mimicked pulse checks/rhythm analyses.
Animals received arterial blood pressure–targeted care
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deﬁned as a compression depth titrated to a target systolic
blood pressure of >90 mm Hg and, starting at minute 9 of the
protocol, vasopressor administration (epinephrine 0.02 mg/kg
and vasopressin 0.4 U/kg) if and only if the CPP was
<20 mm Hg. After 10 minutes of CPR (minute 17 of the
protocol), the initial 200-J biphasic waveform deﬁbrillation
attempt was provided. Resuscitation continued until sustained
ROSC was attained in the CA animals or until minute 27 of the
protocol (an additional 10 minutes of resuscitation post initial
deﬁbrillation attempt). If ROSC was attained, the animals then
received explicit, protocolized post-CA care (see later).
Post-CA Care: CA Animals
After ROSC, animals received explicit protocolized intensive
care, including (1) titration of inspired oxygen concentration
to maintain oxygen saturation at 92% to 96%; (2) titration of
ventilation to maintain end-tidal carbon dioxide between 38
and 42 mm Hg; and (3) intravenous infusions of dopamine (up
to 20 lg/kg per minute) to maintain mean arterial pressure
>55 mm Hg. Anesthesia was maintained with inhaled isoﬂu-
rane (1.0%) during this period.
Experimental Protocol: Sham Animals
Sham animals were also instrumented with central venous
catheters, and anesthesia was maintained with inhaled
isoﬂurane (1.0%). Blood pressure, end-tidal carbon dioxide,
oxygen saturation, temperature, and anesthesia were main-
tained by using the identical explicit post-ROSC protocol as
the treatment group.
Sample Acquisition for Mitochondrial
Assessments
At 4 hours post ROSC in CA animals (5 hours post induction
of anesthesia) and 5 hours post induction of anesthesia in
sham animals, a bilateral craniectomy was performed to
expose the brain. Tissue was rapidly extracted from 2
regions of interest (a 2-cm2 region of left frontal cortex and
both hippocampal regions) while simultaneously receiving a
sodium pentobarbital overdose (150 mg/kg). Tissue was
removed in <10 seconds and placed in ice-cold isolation
buffer (320 mmol/L sucrose, 1.21 g/L tris base, and
2 mmol/L EGTA), where blood, blood vessels, or necrotic
tissue was dissected and disposed from the cortex and
hippocampus. In addition, subcortical white matter was
isolated from the cortex for study. Tissue was then gently
homogenized on ice in MiR05 (110 mmol/L sucrose,
0.5 mmol/L EGTA, 3.0 mmol/L MgCl2, 60 mmol/L K-lacto-
bionate, 10 mmol/L KH2PO4, 20 mmol/L taurine, 20 mmol/L
HEPES, and 1.0 g/L fatty acid–free BSA) by using a 5-mL
Potter-Elvehjem Teﬂon-glass homogenizer (5 strokes over
30 seconds, 3 sets with a pause of 30 seconds between each
Figure 1. Protocol design. Shaded area denotes period of “acute respiratory insufﬁ-
ciency,” induced by endotracheal tube clamping. During the CPR period, animals received
chest compressions with depth titrated to an SBP of 90 mm Hg and vasopressors when the
CPP was <20 mm Hg. ABP indicates arterial blood pressure; CPP, coronary perfusion
pressure; CPR, cardiopulmonary resuscitation; ETT, endotracheal tube; ROSC, return of
spontaneous circulation; SBP, systolic blood pressure; VF, ventricular ﬁbrillation.
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set) to a concentration of 1 mg wet weight tissue/10 lL
MiR05 buffer. We then compared each measure per milligram
of tissue (pmol O2/s9mg) and per citrate synthase activity




A ﬁnal concentration of tissue homogenate suspended in
MiR05 solution was analyzed at a 1 mg/mL concentration, at
a constant 37°C, and the rate of oxygen consumption
was measured by using a high-resolution oxygraph and
expressed in pmol/[s9mg of tissue homogenate]
(OROBOROS, Oxygraph-2K, and DatLab software; all from
OROBOROS Instruments). All experiments were performed at
75 to 220 lmol/L oxygen, and reoxygenation was performed
routinely before addition of the complex IV electron donor as
described later. The oxygraph was calibrated daily: oxygen
concentration was automatically calculated from barometric
pressure and MiR05 oxygen solubility factor was set at 0.92
relative to pure water.22 A substrate, uncoupler, inhibitor
titration protocol (Figure 2) previously used for rodent brain
tissue22 was further developed and optimized in previous
studies in porcine brain tissue.23 Respiratory capacities with
electron ﬂow through both complex I and complex II, as well
as the convergent electron input through the Q-junction
(complexes I and II), were evaluated sequentially by using
succinate and NADH-linked substrates.24 Plasma membranes
were permeabilized with the detergent digitonin to allow non–
membrane-permeable substrates and ADP access to the
subpopulations of mitochondria trapped within synapto-
somes. Further, to achieve similar results in brain tissue
homogenates and isolated brain mitochondria, with a combi-
nation of both subpopulations, Pecinova and colleagues
demonstrated that digitonin is necessary in brain homogenate
preparations.25,26 Without the addition of digitonin, oxidative
phosphorylation capacity would likely be greatly underesti-
mated. Thus, in preliminary experiments, a careful digitonin
dose titration was completed, in the presence of exogenously
administered cytochrome c, which did not induce any
signiﬁcant effect on respiration with the digitonin dose used
in the present study, indicating intact integrity of the outer
mitochondrial membrane (data not shown). The same con-
centration of digitonin was used for both sham and injured
tissue. Routine mitochondrial respiration was established by
the concomitant addition of malate (5 mmol/L) and pyruvate
(5 mmol/L), followed by ADP (1 mmol/L) and glutamate
(5 mmol/L), to measure the oxidative phosphorylation capac-
ity of complex I (OXPHOSCI [where CI is complex I]), driven by
the NADH-related substrates. Sequential additions followed:
Succinate (10 mmol/L) was added to stimulate maximal
phosphorylating respiration capacity via convergent input
through complexes I and II (OXPHOSCI+CII [where CII is
complex II]). Oligomycin, an inhibitor of ATP-synthase, induced
mitochondrial respiration independent of ATP production
across the inner mitochondrial membrane, commonly referred
to as LEAK respiration (LEAKCI+CII) or state 4o. Maximal
convergent nonphosphorylating respiration of the ETS
(ETSCI+CII) was evaluated by titrating the protonophore,
carbonyl cyanide p-(triﬂuoromethoxy)phenylhydrazone until
no further increase in respiration was detected. Rotenone was
added to inhibited complex I–driven respiration and remaining
measured complex II–driven respiration; the ETS capacity
through complex II alone (ETSCII) was measured. The complex
III inhibitor antimycin-A (1 lg/mL) was added to measure the
residual oxygen consumption that is independent of the ETS.
This residual value was subtracted from each of the measured
respiratory states to report ETS function. Finally, complex IV
activity was determined by the addition of ascorbate
(0.8 mmol/L) and N,N,N0,N0-tetramethyl-p-phenylenediamine
(0.5 mmol/L), an electron donor to complex IV. Due to the
high level of auto-oxidation of N,N,N0,N0-tetramethyl-p-
phenylenediamine, sodium azide (10 mmol/L), an inhibitor
of complex IV, was added, and the remaining chemical
background was subtracted to assess complex IV activity. The
substrate, uncoupler, inhibitor titration protocol was identical
for shams and injured tissue. Tissue harvest to completion of
respirometry measurements were completed in all animals in
<1.5 hours. Varying the order of the substrate, uncoupler,
inhibitor titration protocol additions did not affect individual
respiratory state values. Integrated ETS analysis with internal
Figure 2. Oxygen concentration and consumption example
trace from the SUIT protocol. Mitochondrial respiratory states
and respiratory complexes are outlined below the x-axis. The
chamber was opened to increase oxygen concentration to
150 nmol/mL before the addition of TMPD. Anti-A indicates
antimycin-A; ASC/TMPD, ascorbate and N,N,N0,N0-tetramethyl-p-
phenylenediamine; ETS, electron transport system; FCCP, car-
bonyl cyanide p-(triﬂuoromethoxy)phenylhydrazone; Glu, gluta-
mate; M&P, malate+pyruvate; Oligo, oligomycin; OXPHOS,
oxidative phosphorylation; Rot, rotenone; Succ, succinate; SUIT,
substrate, uncoupler, inhibitor titration.
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normalization was generated using ﬂux control ratios (FCRs)
calculated by dividing each respiratory state by the maximal
uncoupled mitochondrial respiration (ETSCI+CII).
Citrate Synthase Determination
On completion of the high-resolution respirometry measure-
ments, chamber contents were frozen at 80°C for subse-
quent citrate synthase (CS) activity quantiﬁcation (Citrate
Synthase Assay Kit, CS0720; Sigma). CS activity (given in
micromoles per milliliter per minute) was used as a marker of
brain metabolism and surrogate for mitochondrial content or
mass secondary to its location within the mitochondrial matrix
and its ability to catalyzes the condensation of oxaloacetate
and the acetyl coenzyme-A, yielding citrate and coenzyme-A in
the ﬁrst step of the tricarboxylic acid cycle.27 Currently, to our
knowledge, there is limited research on biomarkers of
mitochondrial content (CS activity, cardiolipin content, mito-
chondrial DNA content, complexes I to IV protein, and
complexes I to IV) that validates these surrogates against
morphologic measures after acute brain injury, such as
transmission electron microscopy.28,29 To differentiate
whether changes in absolute rates of respiration per amount
of tissue were due to changes in global mitochondrial content
and function or speciﬁc to each respiratory state, we used 2
strategies to normalize the values. First, we used the common
approach of measuring CS activity as a mitochondrial marker
of content. However, the enzyme itself may be altered after
injury devoid of any alteration in mitochondrial content.28 In
addition, ﬂux control ratios were assessed as an internal
normalization of the respiratory states to the maximal
uncoupler-induced rate of respiration within the ETS, a
method that may be independent of tissue heterogeneity.30
All of these methods have strengths and weaknesses; thus,
we decided to present data for each respiratory state in
response to injury in multiple ways: tissue mass, FCR, CS
activity, and ratios for evaluating coupling of respiration
to ATP production and the relative contribution of complex
I– and II–driven respiration to maximal ﬂux. This approach
revealed distinct patterns of mitochondrial respiration after
CA in the immature brain.
Data Analysis/Outcomes
The primary outcomes of this study were ETS respiration and
mitochondrial content. Secondary outcomes consisted of
other recorded variables, including physiologic and hemody-
namic measures, CPR quality variables, and 4-hour survival.
The oxygen ﬂux traces were analyzed using a customized
Matlab (Mathworks) program designed to extract the oxygen
ﬂux plateau at each phase of the substrate, uncoupler,
inhibitor titration protocol, with the exception of N,N,N0,N0-
tetramethyl-p-phenylenediamine/ascorbate, when the peak
oxygen ﬂux was extracted.
Individual assessments of mitochondrial function between
groups (unpaired analysis) were described as median (25th to
75th percentile range) and were compared by using nonpara-
metric Wilcoxon rank sums. Comparison of continuous
variables between regions within animals was similarly
evaluated with use of a sign rank test. Statistical analysis
was completed by using the Stata-IC statistical package
(Version 12.0; StataCorp).
Results
Physiologic and Hemodynamic Variables
In the CA animals, average PaO2 after 6.5 minutes of endotra-
cheal tube–clamped asphyxia (Time 6.5) was 113 mm Hg,
and after 4.5 minutes of CPR (Time 11.5), it was 11014
mm Hg. Hemodynamic measurements (ie, arterial systolic
blood pressure, diastolic blood pressure and CPP) during CPR in
the CA animals demonstrated adherence to experimental
protocol goals (Figure 3). All 5 CA animals studied survived to
4 hours post ROSC.Median number of vasopressor doses given
during the CPR period was 5.5 (range 4 to 6). All animals
achieved sustained ROSC on ﬁrst deﬁbrillation attempt. No
additional vasopressor support was needed post ROSC. In
addition, after ROSC post-CA care, vital signs were arterial
systolic blood pressure 990.6 mm Hg, arterial diastolic blood
pressure 640.5 mm Hg, CPP 390.8 mm Hg, end-tidal
carbon dioxide 400.1 mm Hg, and pulse oximetry 940.4%.
There was no statistical difference in mean vital signs between
CA and sham animals in the post-CA period.
Figure 3. Hemodynamic resuscitation showing systolic, dias-
tolic, and coronary perfusion pressures during CPR period. *First
vasopressor dose. †First shock. Error bars represent SEM. CC
indicates chest compression; CPP, coronary perfusion pressure;
CPR, cardiopulmonary resuscitation.
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Citrate Synthase
There were no differences in CS activity between regions in
sham animals (Figure 4). Further analysis displayed no
differences in CS activity post CA in the cortex (16.8 [14.3
to 17.9] lmol/mL per minute) compared with sham (14.5
[12.8 to 15.6] lmol/mL per minute; P=0.15). However, post
CA, the mitochondrial content as measured by CS activity in
the hippocampus decreased signiﬁcantly, by nearly 30%,
compared with sham (13.9 [10.7 to 15.2] versus 16.9 [15.0 to
18.3] lmol/mL per minute; P<0.04). The results of all
measures of respiratory capacity within the mitochondrial
ETS were also normalized to CS activity for each animal
(Table 1).
Cerebral Mitochondrial Respiration After Hypoxic
VF Pediatric CA
Complex I–driven (OXPHOSCI) respiration and complex
II–driven respiration (ETSCII) were both signiﬁcantly decreased
after CA, in the cortex (OXPHOSCI: P<0.01, ETSCII: P<0.05)
and hippocampus (OXPHOSCI: P<0.03, ETSCII: P<0.01) when
compared per milligram of tissue (Table 1). Reductions in
both complex I– and complex II–driven respiration compared
with sham animals remained signiﬁcant when the data were
normalized for CS (OXPHOSCI: cortex P<0.04, hippocampus
P<0.01; ETSCII: cortex P<0.05, hippocampus P<0.01)
(Table 1) and FCR (OXPHOSCI: cortex P<0.01, hippocampus
P<0.05; ETSCII: cortex P<0.05, hippocampus P<0.01) (Fig-
ure 5A). Consequently, maximal coupled, oxidative phospho-
rylating respiration (OXPHOSCI+CII), stimulated by both
complex I and complex II substrates, was signiﬁcantly
decreased in the cortex (P<0.02) and hippocampus (P<0.02)
per milligram of tissue and remained signiﬁcant when
normalized to CS activity (cortex P<0.01, hippocampus
P<0.01) and FCR (cortex P<0.05, hippocampus P<0.02)
(Figure 5B).
Maximal uncoupled, nonphosphorylating respiration
(ETSCI+CII), initiated by the protonophore carbonyl cyanide
p-(triﬂuoromethoxy)phenylhydrazone after ATP synthase
inhibition with oligomycin, was signiﬁcantly reduced in the
hippocampus (P<0.01) per all measures:milligram of tissue and
normalized to CS, while cortical ETSCI+CII post CA was
signiﬁcantly reduced only per CS (P<0.03) (Table 1). Complex
IV respiration was signiﬁcantly decreased in the hippocampus
per milligram of tissue and normalized to CS activity (P<0.02)
but did not display a signiﬁcant difference in either the cortex or
the hippocampus post CA via FCR. Finally, LEAK (LEAKCI+CII), or
state 4o respiration, did not display a signiﬁcant alteration post
CA compared with sham in either region, except when
normalized to FCR in the cortex and hippocampus, where there
was a signiﬁcant increase (P<0.03) (Figure 5B).
Respiratory ratios evaluating phosphorylation coupling
efﬁciency were calculated for sham and CA animals (Table 2).
The respiratory control ratio for OXPHOSCI+CII (OXPHOSCI+CII/
LEAK) was calculated to determine the efﬁciency of coupled
phosphorylating respiration, a global measure of overall
mitochondrial function, and was signiﬁcantly decreased in
the cortex (P<0.05) and the hippocampus (P<0.05) in CA
compared with sham.
Discussion
These data establish that pediatric animals with ROSC after
severe hypoxia, followed by VF and excellent CPR for
10 minutes, survive; however, they have diffuse cerebral
mitochondrial bioenergetics dysfunction 4 hours after ROSC
compared with sham controls. The pattern of mitochondrial
bioenergetics dysfunction differs from previously described
ﬁndings in mature animals, as we observe signiﬁcant
decreases in both complex I– and complex II–driven respira-
tion, suggesting an important limitation in the immature
brain’s ability to maintain or even accelerate oxidative
phosphorylation in the ﬁrst few hours after CA and challenges
Figure 4. Citrate synthase activity. Four hours after CA there
was a signiﬁcant decrease in CS activity in the hippocampus
compared with sham animals (*P<0.01). The cortex did not
exhibit a signiﬁcant reduction in CS activity post CA. Boxplots:
Horizontal lines represent the median CS activity, with the
boxes representing the 25th and 75th percentiles, the whiskers
representing the 5th and 95th percentiles, and the dots
representing the outlierss. CA indicates cardiac arrest; CS,
citrate synthase.
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the notion that these animals should expect good neurologic
recovery. This persistent cerebral mitochondrial bioenergetic
dysfunction could play an important role in the development
of secondary neurologic injury and reduce the likelihood of
long-term recovery in the at-risk immature brain after survival
from prolonged CA.
Our biochemical analysis of complex interdependent
pathways of electron ﬂow through the ETS revealed an overall
injury pattern with a signiﬁcant decrease in both complex
I– and complex II–driven respiration in the brain 4 hours after
CA despite maintenance of adequate CPP and cerebral
perfusion pressure for successful clinical ROSC. Our method-
ology extends conventional bioenergetic protocols that
use only complex I NADH–linked substrates (pyru-
vate+malate+glutamate) with the addition of the complex II
substrate, succinate (pyruvate+malate+glutamate+succinate),
to maximize oxidative phosphorylation capacity (ATP produc-
tion) by simulating the in situ tricarboxylic acid cycle and
maintaining key substrates for convergent ﬂow of electrons
through complexes I and II.22,31 Consequently, the reductions
in convergent pathways of complexes I and II translated into
signiﬁcant reductions in oxidative phosphorylation post CA,
likely placing the immature brain at signiﬁcant risk due to a
reduced ability to increase its ATP production and maintain
bioenergetic output. Rosenthal and colleagues reported, in
another large animal model of CA with dogs, that mitochon-
drial respiratory inhibition recovered to sham levels by
2 hours after a 10-minute VF CA.32 Our data suggest a more
prolonged period of mitochondrial respiratory inhibition;
however, this may be due to model differences where animals
underwent a prolonged period of hypoxia before VF CA to
simulate pediatric CA. Other confounders complicating the
comparison with Rosenthal and colleagues’ work is the
developmental age of the animal, as well as the techniques
used to obtain mitochondrial respiration.
Complex I–driven respiratory dysfunction is a persistent
characteristic of early mitochondrial dysfunction within 6 to
8 hours after traumatic and ischemic injury in the brain and in
other organ systems such as the heart.33–37 Interestingly, our
data show that both complex I– and complex II–driven
respiration decreased in the immature brain after CA and
resuscitation. This differs from measurements in mature rat
brains exposed to forebrain ischemia and 6 hours of reper-
fusion, which did not show signiﬁcant inhibition of complex
II-–driven respiration with succinate.38 It should be noted that
this model may be distinctly different from the ischemia–
Table 1. Respiration of Brain Tissue Homogenates From Sham and Cardiac Arrest Cohorts
Respiratory Parameters
Per mg of tissue (pmols O2/s9mg)
Sham (n=5) Cardiac Arrest (n=6)
Cortex Hippo Cortex Hippo
OXPHOSCI 42.7 (37 to 49) 50 (30 to 54) 25.0 (22 to 31)* (39%) 22.8 (12 to 26)* (45%)
ETSCII 50.4 (42 to 52) 65.5 (57 to 74) 24.6 (21 to 48)* (50%) 30.8 (21 to 40)* (53%)
OXPHOSCI+CII 85.8 (79 to 89) 105.3 (85 to 115) 47.3 (46 to 81)* (49%) 53.1 (35 to 64)* (50%)
ETSCI+CII 59.2 (51 to 66) 79.1 (65 to 91) 39.4 (37 to 62) (33%) 45.5 (31 to 54)* (44%)
Complex IV 116.0 (110 to 127) 151.4 (135 to 166) 66.8 (51 to 138) (40%) 71.6 (68 to 94)* (50%)
LEAKCI+CII 12.9 (12.5 to 14.6) 15.8 (15.0 to 17.2) 13.6 (12.6 to 16.0) (+5%) 12.6 (8.7 to 15.6)* (20%)
Respiratory Parameters
Per CS Activity (pmols O2/s9CS)
Sham (n=5) Cardiac Arrest (n=6)
Cortex Hippo Cortex Hippo
OXPHOSCI 2.9 (2.5 to 3.8) 2.9 (2.2 to 3.4) 1.6 (1.3 to 1.8)* (39%) 1.5 (1.1 to 1.7)* (45%)
ETSCII 3.4 (2.8 to 3.8) 4.1 (3.9 to 4.2) 1.6 (1.4 to 2.7)* (44%) 2.1 (1.6 to 3.1)* (50%)
OXPHOSCI+CII 6.0 (5.2 to 6.6) 6.4 (5.9 to 6.7) 3.3 (2.9 to 4.6)* (45%) 3.7 (2.8 to 4.9)* (50%)
ETSCI+CII 4.0 (3.4 to 4.6) 5.0 (4.6 to 5.1) 2.3 (1.9 to 3.5)* (41%) 3.2 (2.3 to 3.8)* (36%)
Complex IV 8.0 (7.5 to 9.4) 9.3 (9.1 to 9.6) 4.1 (3.4 to 7.9) (50%) 5.4 (4.7 to 7.9)* (42%)
LEAKCI+CII 0.93 (0.84 to 1.16) 1.02 (0.92 to 1.18) 0.90 (0.77 to 0.96) (+4%) 0.98 (0.53 to 1.16) (4%)
Mitochondrial respiration of brain tissue homogenates from the cortex and hippocampus (Hippo) side in 2 cohorts: sham and 4 hours post CA. Respiration is expressed per mg of tissue
(pmols O2/s9mg), and per citrate synthase activity (pmols O2/s9CS). Presented as median (25th to 75th percentile range). CA indicates cardiac arrest; CS, citrate synthase; ETS, electron
transport system; OXPHOSCI, oxidative phosphorylation capacity of complex I.
*P<0.05 signiﬁcantly different from corresponding sham region. Percent change from sham indicated in parentheses. For deﬁnitions of respiratory states and substrates used, please see
Figure 2.
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Figure 5. Mitochondrial FCR normalized by ETS capacity (ETSCI+CII) measured 4 hours post CA. A, CA resulted in a signiﬁcant decrease in
complex I–driven respiration (OXPHOSCI) in both regions: cortex and hippocampus. Complex II–driven respiration (ETSCII) in CA tissue is
signiﬁcantly decreased bilaterally, compared with corresponding sham tissue. B, Maximal coupled, phosphorylating respiration (OXPHOSCI+CII),
stimulated by both complex I and complex II substrates, was signiﬁcantly decreased post CA in both regions compared with shams. State 4o
(LEAKCI+CII) displayed a signiﬁcant increase 4 hours post CA compared with shams in the cortex and the hippocampus. For deﬁnitions of
respiratory states and substrates, please see Figure 1. *P<0.05. Boxplots: Horizontal lines represent the median FCR, with the boxes
representing the 25th and 75th percentiles, the whiskers representing the 5th and 95th percentiles, and the dots representing the outliers. CA
indicates cardiac arrest; ETS, electron transport system; FCR, ﬂux control ratios; OXPHOSCI+CII, oxidative phosphorylation capacity of complexes
I and II.
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reperfusion injury that occurs after CA. Despite this differ-
ence, several studies suggest that complex II–driven respira-
tion is critical to mitochondrial respiration and salvaging ATP
generation in the ﬁrst several hours of reperfusion after
cerebral ischemia.39,40 Future experiments will focus on
measurements of substrate quantiﬁcation and enzyme activity
for succinate-dependent respiration. Thus, we provide prelim-
inary support for the hypothesis that complex II–targeted
substrate resuscitation may present a plausible candidate
target for therapeutic intervention given its central role in
cerebral energy production after hypoxic–ischemic injury.
Concomitant reduction in both complex I and II respiration in
this study reveals a pattern of injury that suggests speciﬁc
opportunities for mitochondrial-targeted interventions for brain
injury after CA, beyond substrate supplementation. Mitochon-
dria are amajor source of reactive oxygen species generation in
mature animals after reperfusion of the brain after hypoxia,41
and complex I is an important source of cerebral reactive
oxygen species in ischemia and reperfusion.42,43 Niatsetskaya
et al reported that inhibition of complex I with pyridaben was
beneﬁcial and led to a signiﬁcant reduction in oxidative injury
and cerebral infarct volume after hypoxic ischemia in neonatal
mice.33 It is possible that acute attenuation of complex I
respiration after CA in immature animals may be beneﬁcial
despite reductions in ATP production because of the potential
to limit reactive oxygen species generation by attenuating
reverse electron transport during reperfusion.33 However,
chronic reductions in complex I function have been implicated
in exacerbating chronic inﬂammation and cellular destruction
in disease states such as Parkinson’s disease, and may play a
prominent role in persistent bioenergetic dysfunction in other
chronic neurodegenerative processes, such as Alzheimer’s
disease, and, potentially, chronic encephalopathy triggered by
acute brain injury, such as CA.44,45 Future research should
focus on temporal variations in bioenergetic demands and
mechanistic alterations that will inform manipulation of the
mitochondrial respiration in survivors after CA to limit ongoing
neurologic injury.
In contrast to a previous study using mature rodent models
of VF and CPR,46 we did not ﬁnd signiﬁcant global alterations
in LEAKCI+CII, or state 4o, respiration early after ROSC
(with the exception of results normalized to FCR in the
hippocampus). In the context of respiratory control ratios,
OXPHOSCI+CII (state 3) respiration/LEAKCI+CII (state 4o), the
reductions in coupled respiration seem to be driven by
signiﬁcant reductions in OXPHOSCI+CII post CA rather than
signiﬁcant alterations in LEAKCI+CII, or state 4o. Therefore,
we suspect that the global reductions in mitochondrial
respiration, in both the cortex and the hippocampus, were
not due to signiﬁcant uncoupling and increased permeability
of the inner membrane at this time point. Our data suggest
that mitochondrial permeability transition pores do not seem
to be open at 4 hours after CA and add to an important
understanding of the cerebral bioenergetic time-course after
CA. Mitochondrial permeability transition activation is likely
an early and potentially reversible event in ischemia–
reperfusion injury, leading to mitochondrial swelling and
release of cytochrome c that may contribute to global
reductions in mitochondrial respiration seen in our study at
4 hours post CA.47,48
Finally, decreased CS activity in the hippocampus may
parallel signiﬁcant oxidative injury in the at-risk selectively
vulnerable hippocampus after CA.28 Importantly, our data
reveal a substantial reduction of CS activity, by nearly 30%,
within the hippocampus 4 hours after CA. This is presumably
relevant because CS is generally assumed to be the rate-
limiting enzyme of the tricarboxylic acid cycle and, possibly, a
biomarker of mitochondrial content. Future studies will be
performed to design and assess other markers of mitochon-
drial content, such as mitochondrial DNA, which may add to
the assessment of surrogates for evolving mitochondrial
content alterations after injury.
Limitations
Time-course likely plays a signiﬁcant role in alterations of
mitochondrial function after CA. Evaluation of mitochondrial
functionover amorecomprehensive time interval post injurywill
further improve our understanding of bioenergetic alterations
post CA. In an attempt to limit heterogeneity, we also limited our
investigations only to female animals at this time; however,
future investigations should involve male animals to determine
Table 2. Respiratory Ratio of Brain Tissue Homogenates From Sham and Cardiac Arrest Cohorts
Respiratory Ratio
Sham (n=5) Cardiac Arrest (n=6)
Cortex Hippo Cortex Hippo
OXPHOSCI+CII/LEAKCI+CII 6.5 (5.6 to 6.8) 6.4 (5.6 to 6.7) 3.8 (3.4 to 5.1)*
(42%)
3.9 (3.5 to 4.7)*
(40%)
The respiratory control ratio OXPHOSCI+CII/LEAKCI+CII is calculated and presented as median (25th to 75th percentile range). OXPHOSCI+CII indicates the oxidative phosphorylation capacity
of complexes I and II.
*P<0.05 signiﬁcantly different from corresponding sham region. Percent change from sham is indicated in parentheses.
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the applicability of these ﬁndings across sexes in the immature
brain. Other limitations are that this is a descriptive study that
has yet to be correlated with neurologic outcome measures.
Additionally, we have reported that physiologic directed resus-
citation improves neurologic outcomes; however, the Swine
Cerebral Performance Category scales at 24 hours are a gross
measure of both short- and long-term neurologic dysfunction. In
fact, good neurologic outcome was deﬁned by whether an
animal could stand, but could still possess an unsteady gait, be
able to eat, and exhibit a slow response to environmental
stimuli.10,49 Based on this gross scale, there could still be
signiﬁcant neurologic injury. In addition, bioenergetic dysfunc-
tion has been shown to correlate with neurologic injury in other
models; including human studies.50–52 Our current study
generates several hypothesis-driven questions that future
research will address, including the development of and
correlation toshort- and long-termneurologicoutcomes.Finally,
the use of an inhaled volatile anesthetic, isoﬂurane, may affect
mitochondrial respiration. However, both the sham and exper-
imental groups received the same concentrations and duration
of isoﬂurane53; therefore, the differences are likely to remain
meaningful despite the anesthetic.
Conclusions
We have evaluated the mitochondrial bioenergetic response in
the pediatric brain after CA and conclude that there are
signiﬁcant alterations in cerebral mitochondrial respiration
and mitochondrial content in the pediatric brain 4 hours post
ROSC in a large animal model despite excellent CPR,
protocolized postresuscitative care, and improved traditional
survival rates.10 Signiﬁcant alterations in complex I– and
complex II–driven mitochondrial respiration may offer oppor-
tunities for targeted therapeutic interventions in the immature
brain to support post-CA bioenergetic demand by using
substrate-directed resuscitation.
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